| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/28/2023 | Candel Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 14.2k | $1.22 | $17.4k | | 06/28/2023 |
| 12/01/2022 | Renovacor, Inc. | CHAQ | Disposition | Stock Option | 12k | $0.00 | $0 | | 12/01/2022 |
| 12/01/2022 | Renovacor, Inc. | CHAQ | Disposition | Stock Option | 24k | $0.00 | $0 | | 12/01/2022 |
| 12/01/2022 | Renovacor, Inc. | CHAQ | Disposition | Stock Option | 9.1k | $0.00 | $0 | | 12/01/2022 |
| 12/01/2022 | Renovacor, Inc. | CHAQ | Disposition | Common Stock | 3.6k | $0.00 | $0 | | 12/01/2022 |
| 12/01/2022 | Renovacor, Inc. | CHAQ | Grant | Common Stock | 3.6k | $0.00 | $0 | | 12/01/2022 |
| 10/13/2022 | Candel Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 14.2k | $2.81 | $40k | | 10/13/2022 |
| 06/23/2022 | Deciphera Pharmaceuticals, Inc. | DCPH | Grant | Stock Option (Right to Buy) | 18.5k | $13.98 | $258.6k | | 06/23/2022 |
| 05/25/2022 | Renovacor, Inc. | CHAQ | Grant | Stock Option | 12k | $1.94 | $23.3k | | 05/25/2022 |
| 09/03/2021 | Renovacor, Inc. | CHAQ | Grant | Option | 24k | $7.73 | $185.5k | | 09/03/2021 |
| 06/23/2021 | Deciphera Pharmaceuticals, Inc. | DCPH | Grant | Stock Option (Right to Buy) | 12k | $35.86 | $430.3k | | 06/23/2021 |
| 06/10/2020 | Deciphera Pharmaceuticals, Inc. | DCPH | Grant | Stock Option (Right to Buy) | 12k | $56.46 | $677.5k | | 06/10/2020 |
| 06/11/2019 | Deciphera Pharmaceuticals, Inc. | DCPH | Grant | Stock Option (Right to Buy) | 12k | $21.05 | $252.6k | | 06/11/2019 |
| 05/17/2018 | Deciphera Pharmaceuticals, Inc. | DCPH | Grant | Stock Option (Right to Buy) | 12k | $25.73 | $308.8k | | 05/17/2018 |
| 10/02/2017 | Deciphera Pharmaceuticals, Inc. | DCPH | Exercise | Stock Option (Right to Buy) | 7.2k | $6.13 | $44k | | 10/02/2017 |
| 10/02/2017 | Deciphera Pharmaceuticals, Inc. | DCPH | Exercise | Stock Option (Right to Buy) | 1.3k | $6.13 | $7.8k | | 10/02/2017 |
| 10/02/2017 | Deciphera Pharmaceuticals, Inc. | DCPH | Exercise | Stock Option (Right to Buy) | 35.2k | $3.95 | $139.2k | | 10/02/2017 |
| 10/02/2017 | Deciphera Pharmaceuticals, Inc. | DCPH | Exercise | Stock Option (Right to Buy) | 6.2k | $3.95 | $24.6k | | 10/02/2017 |